Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA.
Nature Communications
Paulson, K G KG; Voillet, V V; McAfee, M S MS; Hunter, D S DS; Wagener, F D FD; Perdicchio, M M; Valente, W J WJ; Koelle, S J SJ; Church, C D CD; Vandeven, N N; Thomas, H H; Colunga, A G AG; Iyer, J G JG; Yee, C C; Kulikauskas, R R; Koelle, D M DM; Pierce, R H RH; Bielas, J H JH; Greenberg, P D PD; Bhatia, S S; Gottardo, R R; Nghiem, P P; Chapuis, A G AG